ASX Gems Conference 2024
Our CEO Dr. Michael Baker talks about our biotechnology company, which is focused on developing a unique iNKT cell therapy platform to treat cancer. Watch now on-demand.
Previous
Previous
Arovella funded to Phase 1 data: completes $12.5m placement
Next
Next